These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3828396)

  • 21. Mechanism of the antiplatelet action of dipyridamole in whole blood: modulation of adenosine concentration and activity.
    Gresele P; Arnout J; Deckmyn H; Vermylen J
    Thromb Haemost; 1986 Feb; 55(1):12-8. PubMed ID: 3704998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies to platelet-activating factor (PAF) inhibit PAF-induced platelet aggregation.
    Smal MA; Cooney SJ; Baldo BA
    J Lipid Mediat; 1991 Nov; 4(3):333-41. PubMed ID: 1764578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The synergistic effect of aspirin and dipyridamole upon platelet thrombi in living blood vessels.
    Honour AJ; Hockaday TD; Mann JI
    Br J Exp Pathol; 1977 Jun; 58(3):268-72. PubMed ID: 871376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dipyridamole inhibits platelet aggregation in whole blood.
    Gresele P; Zoja C; Deckmyn H; Arnout J; Vermylen J; Verstraete M
    Thromb Haemost; 1983 Dec; 50(4):852-6. PubMed ID: 6665766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-aggregatory effects of physiological concentrations of adenosine in human whole blood as assessed by filtragometry.
    Söderbäck U; Sollevi A; Wallen NH; Larsson PT; Hjemdahl P
    Clin Sci (Lond); 1991 Nov; 81(5):691-4. PubMed ID: 1661656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effect of cilostazol and dipyridamole mediated by adenosine on shear-induced platelet aggregation.
    Nakamura T; Uchiyama S; Yamazaki M; Iwata M
    Thromb Res; 2007; 119(4):511-6. PubMed ID: 17046050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition by glaucocalyxin A of aggregation of rabbit platelets induced by ADP, arachidonic acid and platelet-activating factor, and inhibition of [3H]-PAF binding.
    Bin Z; Kun L
    Thromb Haemost; 1992 Apr; 67(4):458-60. PubMed ID: 1631795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of in vitro platelet aggregation and its inhibition by three antithrombotic drugs between human and guinea pig.
    Huang ZS; Lee TK
    Proc Natl Sci Counc Repub China B; 1991 Feb; 15(1):8-14. PubMed ID: 1946813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New 1H-pyrazole-4-carboxamides with antiplatelet activity.
    Rehse K; Kotthaus J; Khadembashi L
    Arch Pharm (Weinheim); 2009 Jan; 342(1):27-33. PubMed ID: 19051198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of platelet inhibitor present in the melon (Cucurbitacea cucumis melo).
    Altman R; Rouvier J; Weisenberger H
    Thromb Haemost; 1985 Jun; 53(3):312-3. PubMed ID: 3931281
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhibition of induced thrombocyte aggregation in the presence of endothelial cells by dipyridamole].
    Kirchmaier CM; Altorjay J; Bellinger O; Breddin HK
    Vasa Suppl; 1991; 32():318-21. PubMed ID: 1771524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet-released ADP stabilizes PAF-induced rabbit platelet aggregation by stabilizing intracellular calcium.
    Yi FX; Guo ZG
    Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):379-82. PubMed ID: 10375790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of rat phosphorylcholine-binding protein on platelet aggregation.
    Nagpurkar A; Randell E; Choudhury S; Mookerjea S
    Biochim Biophys Acta; 1988 Oct; 967(1):76-81. PubMed ID: 3167098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation, PGI2 generation, and red cell deformability ex vivo in man.
    Saniabadi AR; Fisher TC; McLaren M; Belch JF; Forbes CD
    Cardiovasc Res; 1991 Mar; 25(3):177-83. PubMed ID: 2029709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet aggregation inhibitors in the prevention of metastasis in neoplastic disease: a review of experimental and clinical investigations.
    Gastpar H; Ambrus JL; Ambrus CM
    J Med; 1981; 12(1):15-33. PubMed ID: 6943264
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen.
    Harfenist EJ; Packham MA; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1981 May; 97(5):680-8. PubMed ID: 6783712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of aspirin and dipyridamole on the degradation of adenosine diphosphate by cultured cells derived from bovine pulmonary artery.
    Crutchley DJ; Ryan US; Ryan JW
    J Clin Invest; 1980 Jul; 66(1):29-35. PubMed ID: 7400307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proceedings: Binding of (14C) dipyradamole (RA 8) to platelets and inhibition of ADP induced platelet aggregation.
    Subbarao K; Rucinski B; Niewarowski S
    Thromb Diath Haemorrh; 1975 Nov; 34(2):552-3. PubMed ID: 1198424
    [No Abstract]   [Full Text] [Related]  

  • 39. The reversibility by dipyridamole of the increased sensitivity of in vivo platelet aggregation in rabbits after alloxan.
    Honour AJ; Hockaday TD; Mann JI
    Br J Exp Pathol; 1976 Feb; 57(1):11-5. PubMed ID: 1268037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiplatelet effect of the pyrimido-pyrimidinic derivative RA-642.
    de la Cruz JP; Moron D; Sanchez de la Cuesta F
    Thromb Res; 1991 Aug; 63(4):463-8. PubMed ID: 1754999
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.